Testing minocycline for brain bleeding recovery
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if the antibiotic minocycline can help people recover after a spontaneous brain bleed (intracerebral hemorrhage). It is for patients who have a moderate-sized bleed and are within 48 hours of symptoms starting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- You had a brain CT scan showing a spontaneous bleed in the upper part of the brain (not caused by injury or other condition).
- The bleed size is between 15 and 40 ml on the CT scan.
- Your symptoms started within the last 48 hours.
- You have a moderate to severe stroke (NIHSS score 8 to 24) and are awake enough to follow commands.
- You or your legal representative can sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how people recover after surgery for a brain bleed (intracerebral hemorrhage). It aims to find the best timing for treatment to improve recovery. If you have had a brain bleed and are eligible for surgery, you may be able to join.
This trial tests whether an antibiotic called minocycline can help people who have had a bleeding stroke (intracerebral hemorrhage). The drug may reduce brain swelling and improve recovery. You must start treatment within 24 hours of the bleeding.
This study looks at people who have had a brain bleed (intracerebral hemorrhage) to learn more about their recovery over time. It does not involve a new treatment but rather follows participants to understand the condition better.
This study tests whether the drug tranexamic acid can help stop bleeding in the brain when given early. It is for people with a spontaneous brain bleed who are awake and can be treated within 6 hours.
This trial tests a non-invasive ultrasound device to help clear blood clots from the brain after a spontaneous bleed. It may be an option for people with small to medium-sized bleeds who do not need surgery.
This trial compares two medicines (deferoxamine and colchicine) to see if they can prevent further brain damage after a spontaneous brain bleed (intracerebral hemorrhage). The goal is to improve recovery by reducing inflammation and iron-related damage.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.